| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 05/17/2001 | WO2000049038A9 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
| 05/17/2001 | WO2000041484A3 Novel use of phospholipids of vegetable and animal origin in nutritional therapy |
| 05/17/2001 | WO2000024755A9 Ovary-specific genes and proteins |
| 05/17/2001 | WO2000002569A3 Compositions for the treatment of atherosclerosis and related conditions |
| 05/17/2001 | DE19954490A1 Reducing salmonellosis in poultry and ornamental birds, by administering competitive lactic acid bacteria isolated from birds |
| 05/17/2001 | DE19954376A1 Culturing of cells, particularly neuronal cells, useful for transplantation for treating neurological disorders such as Parkinson's disease or for gene therapy |
| 05/17/2001 | DE10044129A1 New autogenous vaccine useful in the treatment of autoimmune and allergic diseases |
| 05/17/2001 | CA2391129A1 Lentiviral vector transduction of hematopoietic stem cells |
| 05/17/2001 | CA2390834A1 Transplant/implant device and method for its production |
| 05/17/2001 | CA2390438A1 19 human secreted proteins |
| 05/17/2001 | CA2389982A1 Inhibition of pathogens by bacillus coagulans strains |
| 05/17/2001 | CA2389724A1 28 human secreted proteins |
| 05/17/2001 | CA2389550A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/17/2001 | CA2389524A1 Techniques and compositions for treating cardiovascular disease by in vivo gene delivery |
| 05/17/2001 | CA2389506A1 Nucleic acid-containing complex |
| 05/17/2001 | CA2389488A1 Isolation and expansion of human marrow stromal cells |
| 05/17/2001 | CA2389204A1 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 05/17/2001 | CA2388008A1 29 human secreted proteins |
| 05/16/2001 | EP1099754A1 Mesenchymal stem cells and/or progenitor cells, their isolation and use |
| 05/16/2001 | EP1099445A2 Treatment of neuromuscular disorders and conditions with different botulinum serotype |
| 05/16/2001 | EP1099443A1 Transplant/implant device and method for its production |
| 05/16/2001 | EP1099012A1 Method and apparatus for copper plating using electroless plating and electroplating |
| 05/16/2001 | EP1098986A2 A polynucleotide comprising a ubiquitous chromatin opening element (ucoe) |
| 05/16/2001 | EP1098961A1 Interferon inducing genetically engineered attenuated viruses |
| 05/16/2001 | EP1098959A2 Medium and matrix for long-term proliferation of cells |
| 05/16/2001 | EP1098656A2 Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof |
| 05/16/2001 | EP1084709A9 Oral recombinant lactobacilli vaccines |
| 05/16/2001 | EP0892599A4 Method for removal of psoralens from biological fluids |
| 05/16/2001 | EP0810870B1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof |
| 05/16/2001 | CN1295612A Mutant herpes simplex viruses and uses thereoe |
| 05/16/2001 | CN1294927A Dermatosis treating Chinese medicine and its preparation |
| 05/16/2001 | CN1294926A Chinese medicine preparation for treating angina pectoris and its dispensation process |
| 05/16/2001 | CN1294925A Medicine for treating oviduct obstruction and endometriosis and its preparation |
| 05/16/2001 | CN1294924A Pregnancy promoting medicine to treat man's and woman's sterility and its preparation |
| 05/16/2001 | CN1294919A Cough treating medicine and its preparation |
| 05/16/2001 | CN1294915A Medicine powder for treating beri-beri, smelly foot and sweaty foot |
| 05/16/2001 | CN1065775C Chinese medicine bag for health care |
| 05/16/2001 | CN1065766C Chiense medicine-nasal spray for treatment of rhinitis and its prep. |
| 05/16/2001 | CN1065765C Chinese medicine for curing female endocrinopathy |
| 05/16/2001 | CN1065763C Dizziness-stopping analgesic |
| 05/16/2001 | CN1065762C Medical capsule for regulating insulin and reducing blood and/or uric sugar |
| 05/16/2001 | CN1065749C Medicine for treating hepatitis and tuberculosis |
| 05/16/2001 | CN1065748C Sea horse oral liquor and its preparing method |
| 05/16/2001 | CN1065747C Method for making pearl liquid from pearl or nacrecus layer powder |
| 05/16/2001 | CN1065746C Placenta tonic medicines and prepn. chereof |
| 05/16/2001 | CN1065724C Cow placenta health food and production method thereof |
| 05/15/2001 | US6232460 Isolated nucleic acid molecule which encodes an SCP-1 mutein |
| 05/15/2001 | US6232119 Immortalized human fetal neuronal cell line |
| 05/15/2001 | US6232097 Nucleotide sequences coding enzymatic polypeptide; prevent bacterial infection; wound healing agents; for vaccine development |
| 05/15/2001 | US6232096 Flea serine protease nucleic acid molecules and uses thereof |
| 05/15/2001 | US6231893 Immunosuppressive and tumour-suppressive bone marrow factor |
| 05/15/2001 | US6231881 Medium and matrix for long-term proliferation of cells |
| 05/15/2001 | US6231879 Implantable, biocompatible cell encapsulation with jackets |
| 05/15/2001 | US6231878 Spraying acid water and electrolysis, oxidation-reduction potentials for skins |
| 05/15/2001 | US6231870 Oral administration of pneumoccal antigens |
| 05/15/2001 | US6231770 Biological fluid filter assembly including a plurality of porous media and essentially lacking a solid partition between the media used to deplete leukocytes from two or more units of biological fluid |
| 05/15/2001 | US6231536 Method and compositions for treatments of cancers |
| 05/15/2001 | CA2310845C Treatment of neuromuscular disorders and conditions with different botulinum serotype |
| 05/15/2001 | CA2180011C Botulinum toxins for treating sweating |
| 05/15/2001 | CA2072355C Fibrin sealant delivery method |
| 05/15/2001 | CA1341228C Expression of protein c |
| 05/10/2001 | WO2001032905A1 Process for producing a product containing antihypertensive tripeptides |
| 05/10/2001 | WO2001032898A2 Recombinant sendai virus vector for introducing exogenous genes to airway epithelia |
| 05/10/2001 | WO2001032867A1 Polypeptides with expanded primary signalling motifs |
| 05/10/2001 | WO2001032842A1 ηc NEGATIVE HEMATOPOIETIC PROGENITOR CELLS |
| 05/10/2001 | WO2001032841A2 Method of in vitro t cell differentiation of cd34+ progenitor cells |
| 05/10/2001 | WO2001032840A2 Hair transplantation |
| 05/10/2001 | WO2001032836A1 Lactobacillus helvetius producing antihypertensive di- and tripeptides |
| 05/10/2001 | WO2001032709A2 Polypeptides with non-natural primary signalling motifs |
| 05/10/2001 | WO2001032704A1 Choline transporter like (ctl) membrane proteins involved in choline transport |
| 05/10/2001 | WO2001032687A1 10 human secreted proteins |
| 05/10/2001 | WO2001032685A2 Gene expression directed by a super-psa promoter |
| 05/10/2001 | WO2001032675A1 32 human secreted proteins |
| 05/10/2001 | WO2001032614A2 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 05/10/2001 | WO2001032289A1 Methods for preparing blood or plasma component solutions with improved concentrations |
| 05/10/2001 | WO2001032224A1 Method of inactivating pathogens |
| 05/10/2001 | WO2001032222A1 Selective toxin expression in angiogenic endothelial cells |
| 05/10/2001 | WO2001032221A1 Dna-vaccines based on constructs derived from the genomes of human and animal pathogens |
| 05/10/2001 | WO2001032209A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 05/10/2001 | WO2001032205A1 Mucosal preventives for mastitis |
| 05/10/2001 | WO2001032189A1 Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 05/10/2001 | WO2001032137A1 Slimming composition containing a substance inducing il-6 production |
| 05/10/2001 | WO2001032129A2 Augmentation and repair of age-related soft tissue defects |
| 05/10/2001 | WO2001032128A2 Human chemokine beta-13 |
| 05/10/2001 | WO2001032038A1 Fibrous-liponutritional complexes and compositions containing them |
| 05/10/2001 | WO2001032009A1 Propagation of human hepatocytes in non-human animals |
| 05/10/2001 | WO2001021804B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/10/2001 | WO2001021766A8 Methods and devices for obtaining non-hematopoietic lineage cells from hematopoietic progenitor cells |
| 05/10/2001 | WO2001019379A3 Methods for treating muscular dystrophy with bone marrow cells |
| 05/10/2001 | WO2001019378A3 Solid lipid formulations comprising an inhibitor of lipases and a fatty acid ester of polyols |
| 05/10/2001 | WO2001011011A3 Multipotent adult stem cells and methods for isolation |
| 05/10/2001 | WO2001006949A3 In vitro repair of bone and/or cartilage defects |
| 05/10/2001 | WO2000078327A3 Agents for treating malignant diseases using e1a-deficient adenoviruses with yb-1 protein-dependent replication |
| 05/10/2001 | WO2000077207A3 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto |
| 05/10/2001 | WO2000064488A3 Somatic transgene immunization and related methods |
| 05/10/2001 | WO2000063241A3 Methods and compositions for modulating an immune response |
| 05/10/2001 | WO2000061170A3 Novel medical use of alpha-1-acidic glycoprotein (aag or orosomucoid) |
| 05/10/2001 | WO2000047720A3 Pancreatic progenitor cells, methods and uses related thereto |
| 05/10/2001 | US20010001041 Homogenizing a tissue in a nondenaturing aqueous solvent to obtain particles; aqueous solvent extraction; separation of solid and liquid; fractionating and purifying; inhibitors of matrix metalloprotease and angiogenesis; antitumor agents |
| 05/10/2001 | US20010001039 Wound healing agents, especially for chronic wounds, e.g., diabetic wounds, ulcers, using keratinocytes grown on a transplantable solid support, e.g. collagen-coated beads; enclosure of mesh housing the support and placed in the wound |